v. 14 – 2020/02
| Market Executive Summary |
Initial implementation phase: 2019-2020
The start is postponed until the 1st of Nov, 2020. Non-serialized medicines, put into circulation before the deadline, will remain until their expiration. Following the re-orientation of the program earlier in the year, the current status is an ongoing debate about the preferred model (use of cryptocode vs. EU-FMD style coding) with a likely preference to follow EU-FMD example. |
| Key Dates |
|